A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD).
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Aripiprazole (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Feb 2017 Last checked against ClinicalTrials.gov record.
- 03 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.